Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $96.38M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 2.13M
Average 1.15M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Quanterix Corporation
NASDAQ:QTRX
Intrinsic Alpha fair value
Locked
Current Price
$2.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +9.5% | +10.0% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at +9.5% over three years. Forward estimates point to Revenue at +10.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Sight Sciences, Inc. NASDAQ:SGHT | $601.92M | $10.83 | Not rated | -7.5 | +59.94% |
Senseonics Holdings, Inc. NASDAQ:SENS | $579.58M | $10.58 | Not rated | -3.5 | +68.98% |
908 Devices Inc. NASDAQ:MASS | $405.01M | $9.74 | Not rated | -9.0 | +64.39% |
Viemed Healthcare, Inc. NASDAQ:VMD | $347.48M | $9.17 | Undervalued | 27.4 | +35.59% |
Immuneering Corporation NASDAQ:IMRX | $240.27M | $3.71 | Not rated | -3.6 | -50.64% |
Inogen, Inc. NASDAQ:INGN | $147.95M | $5.69 | Not rated | -7.0 | -17.75% |
Outset Medical, Inc. NASDAQ:OM | $70.32M | $3.73 | Not rated | -1.2 | -34.46% |
Nano-X Imaging Ltd. NASDAQ:NNOX | $25.36M | $0.32 | Not rated | -1.5 | -78.79% |
CVRx, Inc. NASDAQ:CVRX | $17.30M | $0.61 | Not rated | -2.5 | -70.11% |
SANUWAVE Health, Inc. NASDAQ:SNWV | $15.66M | $1.82 | Undervalued | 5.0 | -81.50% |
Continue the stock analysis
Jump to another research area for this company.